Carnosic Acid and Its Semisynthetic Derivatives as Promising Anticancer Agents
International Journal of Molecular Sciences · 23.01.2026 · 27 (3) · 1149
DOI: 10.3390/ijms27031149 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 23.01.2026. Verfasst von Sara P S P Moura und 2 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Coimbra, 3000-548 Coimbra, Portugal. Hauptthemen laut MEDLINE: Abietanes, Antineoplastic Agents, Neoplasms, Antineoplastic Agents, Phytogenic. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação para a Ciência e Tecnologia, FCT—Fundação para a Ciência e a Tecnologia, Universidade de Coimbra.
Abstract (Originalsprache)
Natural products are a valuable source of structurally diverse bioactive compounds, many of which have contributed significantly to the discovery of new anticancer drugs. Carnosic acid 1, an abietane-type diterpenoid primarily found in rosemary and sage, has emerged as a promising scaffold due to its ability to modulate key cellular pathways involved in cancer development and progression, including the cell cycle, apoptosis, autophagy, inflammation, and oxidative stress. Despite its multifaceted approach to combat cancer and promising results obtained in vitro and in vivo, its moderate potency limits its clinical application. To address this limitation, several chemical modifications have been performed to generate semisynthetic derivatives with improved efficacy. Several semisynthetic derivatives have demonstrated significantly enhanced anticancer activity across diverse cancer models, highlighting the importance of structural optimization of the carnosic acid 1 backbone. This review provides a comprehensive overview of carnosic acid 1 and its semisynthetic derivatives, focusing on their anticancer activities, underlying molecular mechanisms, and structure–activity relationships, with the aim of guiding the future design and development of carnosic acid 1-derived anticancer drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Coimbra, 3000-548 Coimbra, Portugal.
- Center for Neuroscience and Cell Biology (CNC), University of Coimbra, 3004-504 Coimbra, Portugal.
- Centre for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, 3004-504 Coimbra, Portugal.
- Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, 00014 Helsinki, Finland.
ORCID-Profile: Sara P S P Moura, Vânia M Moreira, Jorge A R Salvador
Förderung
- Fundação para a Ciência e Tecnologia
- FCT—Fundação para a Ciência e a Tecnologia
- Universidade de Coimbra
Zitieren
APA
Moura, S. P. S. P., Moreira, V. M., & Salvador, J. A. R. (2026). Carnosic Acid and Its Semisynthetic Derivatives as Promising Anticancer Agents. International Journal of Molecular Sciences, 27(3), 1149. https://doi.org/10.3390/ijms27031149
Vancouver
Moura SPSP, Moreira VM, Salvador JAR. Carnosic Acid and Its Semisynthetic Derivatives as Promising Anticancer Agents. International Journal of Molecular Sciences. 2026;27(3):1149. doi:10.3390/ijms27031149
BibTeX
@article{Moura2026,
author = {Moura, Sara P S P and Moreira, Vânia M and Salvador, Jorge A R},
title = {Carnosic Acid and Its Semisynthetic Derivatives as Promising Anticancer Agents},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {3},
pages = {1149},
doi = {10.3390/ijms27031149}
}
EUVIMED